Vaccine therapy of malignant melanoma

This publication has 59 references indexed in Scilit:

• A Population-Based Validation of the American Joint Committee on Cancer Melanoma Staging System
  Journal of Clinical Oncology, 2005
• A listing of human tumor antigens recognized by T cells: March 2004 update
  Cancer Immunology, Immunotherapy, 2004
• Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
  Cancer, 2004
• Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
  Seminars in Cancer Biology, 2003
• Adoptive-cell-transfer therapy for the treatment of patients with cancer
  Nature Reviews Cancer, 2003
• Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune Responses
  Annual Review of Immunology, 2002
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatography
  International Journal of Cancer, 1993
• Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine
  Annals of Surgery, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991